The direct answer is no. The U.S. Food and Drug Administration does not issue certificates, letters or emails that prove compliance with cosmetic facility registration or product listing requirements. A facility registration number or product listing number also does not mean that FDA has approved a factory, formula or finished cosmetic product.
That does not make registration and listing optional. It changes what a buyer should request. Instead of asking a supplier for one document called an “FDA certificate,” build a verification pack that connects the legal entities, current facility status, product listing, label version, safety records and change history for the exact skincare product intended for the U.S. market.
This article serves one sourcing question: what should a U.S. private label skincare buyer verify before treating FDA-related documents as sufficient for an order or marketplace submission?
On September 9, 2026, FDA stated that it does not provide certificates or other documents to verify compliance for cosmetic product facility registration. The agency also said it does not provide a verification letter or email confirming that a facility is registered, that a cosmetic product is listed, or that an entity is exempt from registration or listing.
FDA made two distinctions that buyers should preserve in their own records:
Neither action is an FDA cosmetic approval program. The number is a record identifier and a verification input, not a promotional claim.
FDA also noted that ecommerce platforms may ask sellers for proof of registration or for documentation related to an exemption. Platform evidence requests therefore need to be translated into the documents and status information that actually exist. A seller should not solve the request by creating or buying a certificate that FDA does not issue.
Facility registration concerns the manufacturing or processing facility. FDA’s Cosmetics Direct materials now display registration status and renewal date, and required facilities generally renew every two years from the date of initial registration.
Product listing concerns each marketed cosmetic product and the responsible person whose name appears on the label. FDA states that the listing includes product ingredients and that updates are provided annually.
FDA does not pre-approve cosmetic products or most cosmetic ingredients. Certain color additives are an important exception. A cosmetic must still be safe, properly labelled and compliant with applicable U.S. requirements, but registration and listing numbers do not establish approval.
An FDA cosmetic verification pack is a version-controlled set of records that shows who is responsible, which facility and product records apply, what version will be sold, and when each status must be reviewed.
Record the legal name of the facility operator, the U.S. agent where applicable, the brand or sales entity, and the responsible person named on the label. Do not assume that a trading company, brand owner and manufacturing facility are the same entity.
The map should answer: who manufactures or processes the product, who owns the label version, who submits or maintains the listing, and who receives regulatory or marketplace questions?
Keep the relevant facility identifier, current registration status, initial registration date and renewal date together. A screenshot or exported record should include a review date and the entity it belongs to.
FDA says facility registration is renewed every two years. Its 2026 Cosmetics Direct update added visible registration-status and renewal-date fields. For sourcing teams, this means that a number without a current status and date is incomplete evidence.
Map every commercial SKU to the actual formula, product category, ingredient version, pack size and responsible person. If several variants share a base formula, document exactly what is shared and what differs.
The purpose is not to collect the greatest number of reference numbers. It is to stop a listing for one formula, label or responsible person from being presented as evidence for every product in a catalog.
Registration and listing do not replace safety substantiation or compliant labelling. The file should connect the marketed product to its ingredient record, safety-supporting documents, label artwork and planned claims.
U.S. product classification also depends on intended use. Claims to treat disease or affect the structure or function of the body may cause a product to be regulated as a drug. Sunscreen claims are a common example of a product moving beyond a cosmetics-only pathway. Buyers should therefore review the exact packaging, listing copy and creator scripts rather than approving claims from a generic sales sheet.
Record what changed, when it changed, who approved the update and which files or submissions were affected. Triggers may include a change in formula, ingredient statement, responsible person, facility information, artwork, product discontinuation or relisting.
The log should also identify the next review date. This keeps marketplace evidence, supplier records and the commercial product version aligned after the first launch.
Confirm that the project is specifically intended for the United States. Map the exact stock SKU to its formula and label, identify the responsible person, and verify which facility and product records apply. “In stock” does not mean “ready for U.S. sale.”
If the buyer changes the brand, pack size, artwork, product name or responsible person, review which listing information and marketplace materials must change. Keep the approved sample and artwork version in the same record.
Connect the formula, safety substantiation, label, claims, responsible person, facility record, product listing and production batch through one controlled project file. The deeper the customization, the less useful a standalone certificate becomes.
This checklist does not determine whether a particular company qualifies for an exemption. It does not replace U.S. legal advice, FDA guidance or marketplace-specific review. It also does not prove that a formula is safe, that a claim is allowed, or that the same product version can be sold in another country.
Exact requirements depend on the product, intended use, facility role, responsible person, ingredients, claims and current regulatory position. Buyers should use the pack to organize verification and identify gaps, then obtain qualified regulatory or legal advice where needed.
Guangzhou Lianbiquan Biological Technology Co., Ltd., with Lanthome Skincare as its official website presence, is based in Guangzhou. Its public website presents face, hair, body and eye-care products and OEM/ODM services.
For U.S.-bound private label skincare, Lanthome Skincare can help buyers structure candidate-product screening, stock-product tests, small-batch options, light customization, packaging combinations and OEM/ODM development around a controlled product version. The project team can also organize the questions needed to connect samples, formulas, artwork, documents and replenishment decisions.
This support is not an FDA approval or a guarantee of marketplace acceptance. Price, inventory, MOQ, lead time, formula availability, compliance documentation, overseas fulfilment and dropshipping options must be confirmed for the specific product, destination market and current project conditions.
Send your target country, sales platform, budget and expected quantity. Lanthome Skincare can help determine whether the practical next step is stock testing, light customization or an OEM/ODM program, and which verification records should be requested before commitment.
